{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:58:18Z","timestamp":1780365498105,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work has been supported by the Jiangsu Provincial Health and Health Commission Research Project","award":["K2024084, JSZJ20241204"],"award-info":[{"award-number":["K2024084, JSZJ20241204"]}]},{"name":"This work has been supported by the Jiangsu Provincial Health and Health Commission Research Project","award":["K2024084, JSZJ20241204"],"award-info":[{"award-number":["K2024084, JSZJ20241204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To analyze clinical and laboratory data of patients, identify indicators associated with lymph node metastasis (LNM) in papillary thyroid microcarcinoma (PTMC), and develop a nomogram and web-based calculator for predicting LNM risk. A retrospective analysis was performed on 754 patients who underwent PTMC resection between January 2018 and July 2023. Patients were randomly divided into a modeling set and a validation set at a 7:3 ratio. Independent predictive factors for LNM were identified using LASSO-logistic regression, and a nomogram was constructed. Model discrimination and calibration were assessed using ROC curves, calibration plots, the C-index, and the Hosmer\u2013Lemeshow test. The modeling set included 528 cases (392 non-metastatic, 136 metastatic), and the validation set comprised 226 cases (175 non-metastatic, 51 metastatic). LASSO-logistic regression identified nodule diameter, gender, albumin, apolipoprotein B, and thyroglobulin as independent predictors of LNM. The predictive model achieved AUROC values of 0.758 in the modeling set and 0.696 in the validation set. Calibration plots, the C-index, and the Hosmer\u2013Lemeshow test demonstrated good agreement between predicted and observed risks. Decision curve analysis (DCA) and clinical impact curves (CIC) indicated favorable clinical benefit and impact. The model was also implemented as a freely accessible web-based calculator (https:\/\/ley120.shinyapps.io\/Lymph_Node_Metastasis_in_PTMC\/). This study developed a nomogram and web-based calculator to predict LNM risk in PTMC. The model may assist clinicians in estimating LNM risk by entering relevant patient variables. This study was registered in the Chinese Clinical Trial Registry (ChiCTR2400080625).<\/jats:p>","DOI":"10.1038\/s41598-025-28483-8","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:14:08Z","timestamp":1764054848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personalized prediction of lymph node metastasis in papillary thyroid microcarcinoma: a nomogram and web calculator"],"prefix":"10.1038","volume":"15","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anquan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"28483_CR1","doi-asserted-by":"publisher","unstructured":"Wu, L. et al. Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study. Eur. Thyroid J. 12(6), https:\/\/doi.org\/10.1530\/ETJ-23-0127 (2023).","DOI":"10.1530\/ETJ-23-0127"},{"key":"28483_CR2","doi-asserted-by":"publisher","first-page":"e942619","DOI":"10.12659\/MSM.942619","volume":"30","author":"A Aras","year":"2024","unstructured":"Aras, A. & Karay\u0131l, A. R. Optimal surgical approaches for thyroid cancer: A comparative analysis of efficacy and complications. Med. Sci. Monit. 30, e942619. https:\/\/doi.org\/10.12659\/MSM.942619 (2024).","journal-title":"Med. Sci. Monit."},{"key":"28483_CR3","doi-asserted-by":"publisher","unstructured":"Zhang, H. et al. TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting the PI3K\/AKT pathway and EMT. Endocr. Connect. 13(12), https:\/\/doi.org\/10.1530\/EC-24-0270 (2024).","DOI":"10.1530\/EC-24-0270"},{"issue":"2","key":"28483_CR4","doi-asserted-by":"publisher","first-page":"e2404491","DOI":"10.1002\/advs.202404491","volume":"12","author":"G Zheng","year":"2025","unstructured":"Zheng, G. et al. Spatial and Single-Cell transcriptomics unraveled Spatial evolution of papillary thyroid cancer. Adv. Sci. (Weinh). 12 (2), e2404491. https:\/\/doi.org\/10.1002\/advs.202404491 (2025).","journal-title":"Adv. Sci. (Weinh)"},{"key":"28483_CR5","doi-asserted-by":"publisher","unstructured":"Liang, W. et al. FLNA overexpression promotes papillary thyroid cancer aggression via the FAK\/AKT signaling pathway. Endocr. Connect. 13(6), https:\/\/doi.org\/10.1530\/EC-24-0034 (2024).","DOI":"10.1530\/EC-24-0034"},{"issue":"1","key":"28483_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s40644-024-00803-7","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Prediction of lateral lymph node metastasis with short diameter less than 8\u00a0mm in papillary thyroid carcinoma based on radiomics. Cancer Imaging. 24 (1), 155. https:\/\/doi.org\/10.1186\/s40644-024-00803-7 (2024).","journal-title":"Cancer Imaging"},{"key":"28483_CR7","doi-asserted-by":"publisher","first-page":"1352503","DOI":"10.3389\/fendo.2024.1352503","volume":"15","author":"X Kong","year":"2024","unstructured":"Kong, X., Wang, L., Sun, Y., Zhu, D. & Yang, C. Comparison of radiofrequency ablation and surgery for thyroid papillary microcarcinoma: efficacy, safety and life quality. Front. Endocrinol. (Lausanne). 15, 1352503. https:\/\/doi.org\/10.3389\/fendo.2024.1352503 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"28483_CR8","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.21037\/qims-24-457","volume":"14","author":"YP Yang","year":"2024","unstructured":"Yang, Y. P. et al. Diagnostic efficacy of the contrast-enhanced ultrasound thyroid imaging reporting and data system classification for benign and malignant thyroid nodules. Quant. Imaging Med. Surg. 14 (8), 5721\u20135736. https:\/\/doi.org\/10.21037\/qims-24-457 (2024).","journal-title":"Quant. Imaging Med. Surg."},{"key":"28483_CR9","doi-asserted-by":"publisher","unstructured":"Saez de Gordoa, K. et al. Validation of the Updated Porto Proposal in Papillary Thyroid Microtumors: Analysis of Cases at a University Hospital in Catalonia, Spain. Cancers (Basel) 17(12), https:\/\/doi.org\/10.3390\/cancers17122021 (2025).","DOI":"10.3390\/cancers17122021"},{"key":"28483_CR10","doi-asserted-by":"publisher","first-page":"1075598","DOI":"10.3389\/fendo.2023.1075598","volume":"14","author":"T Ma","year":"2023","unstructured":"Ma, T., Wang, L., Zhang, X. & Shi, Y. A clinical and molecular pathology prediction model for central lymph node metastasis in cN0 papillary thyroid microcarcinoma. Front. Endocrinol. (Lausanne). 14, 1075598. https:\/\/doi.org\/10.3389\/fendo.2023.1075598 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"28483_CR11","doi-asserted-by":"publisher","unstructured":"Zhang, W. et al. PROS1-MERTK axis drives tumor microenvironment crosstalk and progression in papillary thyroid microcarcinoma. Adv. Sci. (Weinh). e13474. https:\/\/doi.org\/10.1002\/advs.202413474 (2025).","DOI":"10.1002\/advs.202413474"},{"key":"28483_CR12","doi-asserted-by":"publisher","unstructured":"Marongiu, A. et al. Minimal extrathyroid extension (mETE) as the only risk factor in patients with papillary thyroid carcinoma (PC): its clinical impact on recurrence and outcome during Long-Term Follow-Up. Biomedicines 12 (2). https:\/\/doi.org\/10.3390\/biomedicines12020350 (2024).","DOI":"10.3390\/biomedicines12020350"},{"key":"28483_CR13","doi-asserted-by":"publisher","unstructured":"Marongiu, A. et al. Hashimoto\u2019s Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor. Diagnostics (Basel) 13(19), https:\/\/doi.org\/10.3390\/diagnostics13193068 (2023).","DOI":"10.3390\/diagnostics13193068"},{"issue":"1","key":"28483_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41417-024-00854-9","volume":"32","author":"Z Cao","year":"2025","unstructured":"Cao, Z. et al. Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis. Cancer Gene Ther. 32 (1), 38\u201350. https:\/\/doi.org\/10.1038\/s41417-024-00854-9 (2025).","journal-title":"Cancer Gene Ther."},{"issue":"2","key":"28483_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/01617346251313982","volume":"47","author":"L Gao","year":"2025","unstructured":"Gao, L. et al. The predictive value of a nomogram based on ultrasound Radiomics, clinical Factors, and enhanced ultrasound features for central lymph node metastasis in papillary thyroid microcarcinoma. Ultrason. Imaging. 47 (2), 93\u2013103. https:\/\/doi.org\/10.1177\/01617346251313982 (2025).","journal-title":"Ultrason. Imaging"},{"key":"28483_CR16","doi-asserted-by":"publisher","first-page":"1164069","DOI":"10.3389\/fendo.2023.1164069","volume":"14","author":"H Zhao","year":"2023","unstructured":"Zhao, H., Hu, J., Cui, L., Gong, Y. & Huang, T. Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma. Front. Endocrinol. (Lausanne). 14, 1164069. https:\/\/doi.org\/10.3389\/fendo.2023.1164069 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"28483_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12885-023-11219-0","volume":"23","author":"H Huang","year":"2023","unstructured":"Huang, H., Xu, S., Ni, S., Wang, X. & Liu, S. A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma. BMC Cancer. 23 (1), 718. https:\/\/doi.org\/10.1186\/s12885-023-11219-0 (2023).","journal-title":"BMC Cancer"},{"issue":"3","key":"28483_CR18","doi-asserted-by":"publisher","first-page":"e25536","DOI":"10.1016\/j.heliyon.2024.e25536","volume":"10","author":"B Li","year":"2024","unstructured":"Li, B., Qian, Y., Huang, Y. & Li, Z. Efficacy and safety of thermal ablation modalities for the treatment of papillary thyroid microcarcinoma: systematic review and network meta-analysis. Heliyon 10 (3), e25536. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25536 (2024).","journal-title":"Heliyon"},{"issue":"3","key":"28483_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1089\/thy.2020.0317","volume":"31","author":"SR Chung","year":"2021","unstructured":"Chung, S. R. et al. Interobserver reproducibility in sonographic measurement of diameter and volume of papillary thyroid microcarcinoma. Thyroid 31 (3), 452\u2013458. https:\/\/doi.org\/10.1089\/thy.2020.0317 (2021).","journal-title":"Thyroid"},{"key":"28483_CR20","doi-asserted-by":"publisher","first-page":"981495","DOI":"10.3389\/fonc.2022.981495","volume":"12","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Active surveillance of highly suspicious thyroid nodules cohort in China shows a worse psychological status in younger patients. Front. Oncol. 12, 981495. https:\/\/doi.org\/10.3389\/fonc.2022.981495 (2022).","journal-title":"Front. Oncol."},{"issue":"4","key":"28483_CR21","doi-asserted-by":"publisher","first-page":"e23905","DOI":"10.1097\/MD.0000000000023905","volume":"100","author":"Y Du","year":"2021","unstructured":"Du, Y., Jiang, Y., Tang, S. & Li, L. Diagnostic value of routine ultrasonography combined with ultrasound elastography for papillary thyroid microcarcinoma: A protocol for systematic review and meta-analysis. Med. (Baltim). 100 (4), e23905. https:\/\/doi.org\/10.1097\/MD.0000000000023905 (2021).","journal-title":"Med. (Baltim)."},{"key":"28483_CR22","doi-asserted-by":"publisher","first-page":"153303382412975","DOI":"10.1177\/15330338241297599","volume":"23","author":"X Yuan","year":"2024","unstructured":"Yuan, X. et al. A Clinical Retrospective Study on the Qualitative Value of Multimodal Ultrasonography for ACR-TIRADS 4 Thyroid Nodules Ranging from 1\u00a0cm to 1.5\u2005cm. Technol. Cancer Res. Treat. 23, 15330338241297599. https:\/\/doi.org\/10.1177\/15330338241297599 (2024).","journal-title":"Technol. Cancer Res. Treat."},{"key":"28483_CR23","doi-asserted-by":"publisher","first-page":"1429382","DOI":"10.3389\/fendo.2024.1429382","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with hashimoto\u2019s thyroiditis: BRAF May not be a valuable predictor. Front. Endocrinol. (Lausanne). 15, 1429382. https:\/\/doi.org\/10.3389\/fendo.2024.1429382 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"28483_CR24","doi-asserted-by":"publisher","first-page":"9542","DOI":"10.1038\/s41598-025-92295-z","volume":"15","author":"Y Guo","year":"2025","unstructured":"Guo, Y. et al. Predictive risk-scoring model for lateral lymph node metastasis in papillary thyroid carcinoma. Sci. Rep. 15 (1), 9542. https:\/\/doi.org\/10.1038\/s41598-025-92295-z (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"28483_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1186\/s12885-024-12459-4","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Pathomics and single-cell analysis of papillary thyroid carcinoma reveal the pro-metastatic influence of cancer-associated fibroblasts. BMC Cancer. 24 (1), 710. https:\/\/doi.org\/10.1186\/s12885-024-12459-4 (2024).","journal-title":"BMC Cancer"},{"key":"28483_CR26","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1038\/srep07748","volume":"5","author":"YR Hong","year":"2015","unstructured":"Hong, Y. R. et al. Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases. Sci. Rep. 5, 7748. https:\/\/doi.org\/10.1038\/srep07748 (2015).","journal-title":"Sci. Rep."},{"issue":"2","key":"28483_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40618-024-02434-y","volume":"48","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. The role of TMEM163 protein in thyroid microcarcinoma: expression pattern and clinical implications. J. Endocrinol. Invest. 48 (2), 303\u2013315. https:\/\/doi.org\/10.1007\/s40618-024-02434-y (2025).","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"28483_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1021\/acs.jproteome.4c00737","volume":"24","author":"Q Zhang","year":"2025","unstructured":"Zhang, Q. et al. Proteomic analysis of tissue proteins related to lateral lymph node metastasis in papillary thyroid microcarcinoma. J. Proteome Res. 24 (1), 256\u2013267. https:\/\/doi.org\/10.1021\/acs.jproteome.4c00737 (2025).","journal-title":"J. Proteome Res."},{"key":"28483_CR29","doi-asserted-by":"publisher","first-page":"1354288","DOI":"10.3389\/fonc.2024.1354288","volume":"14","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Application of ultrasound elastography and radiomic for predicting central cervical lymph node metastasis in papillary thyroid microcarcinoma. Front. Oncol. 14, 1354288. https:\/\/doi.org\/10.3389\/fonc.2024.1354288 (2024).","journal-title":"Front. Oncol."},{"issue":"1","key":"28483_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13044-024-00191-x","volume":"17","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Ultrasound radiomics signature for predicting central lymph node metastasis in clinically node-negative papillary thyroid microcarcinoma. Thyroid Res. 17 (1), 4. https:\/\/doi.org\/10.1186\/s13044-024-00191-x (2024).","journal-title":"Thyroid Res."},{"key":"28483_CR31","doi-asserted-by":"publisher","first-page":"1108125","DOI":"10.3389\/fendo.2023.1108125","volume":"14","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. Predictive nomogram for central lymph node metastasis in papillary thyroid microcarcinoma based on pathological and ultrasound features. Front. Endocrinol. (Lausanne). 14, 1108125. https:\/\/doi.org\/10.3389\/fendo.2023.1108125 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"28483_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2017.01.046","author":"FN Tessler","year":"2017","unstructured":"Tessler, F. N. et al. White Paper of the ACR TI-RADS Committee. J. Am. Coll. Radiol. 14 (5), 587\u2013595. https:\/\/doi.org\/10.1016\/j.jacr.2017.01.046 (2017). ACR Thyroid Imaging, Reporting and Data System (TI-RADS)."},{"key":"28483_CR33","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385, e078378. https:\/\/doi.org\/10.1136\/bmj-2023-078378 (2024).","journal-title":"BMJ"},{"issue":"8","key":"28483_CR34","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1177\/0962280218784726","volume":"28","author":"M van Smeden","year":"2019","unstructured":"van Smeden, M. et al. Sample size for binary logistic prediction models: beyond events per variable criteria. Stat. Methods Med. Res. 28 (8), 2455\u20132474. https:\/\/doi.org\/10.1177\/0962280218784726 (2019).","journal-title":"Stat. Methods Med. Res."},{"key":"28483_CR35","doi-asserted-by":"publisher","first-page":"107327482210849","DOI":"10.1177\/10732748221084926","volume":"29","author":"Y Shi","year":"2022","unstructured":"Shi, Y. et al. Clinicopathological findings associated with cervical lymph node metastasis in papillary thyroid microcarcinoma: A retrospective study in China. Cancer Control. 29, 10732748221084926. https:\/\/doi.org\/10.1177\/10732748221084926 (2022).","journal-title":"Cancer Control"},{"issue":"5","key":"28483_CR36","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1177\/00031348211069801","volume":"89","author":"WZ Ruo","year":"2023","unstructured":"Ruo, W. Z. et al. Risk factors for Level-VII lymph node metastases of thyroid neoplasms: A Meta-Analysis. Am. Surg. 89 (5), 1673\u20131681. https:\/\/doi.org\/10.1177\/00031348211069801 (2023).","journal-title":"Am. Surg."},{"issue":"1","key":"28483_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12902-023-01375-6","volume":"23","author":"X Xie","year":"2023","unstructured":"Xie, X., Deng, J., Zheng, B., Zhong, L. & Miao, J. The effect of central lymph node dissection on the prognosis of cN0 papillary thyroid microcarcinoma: a mid-term follow-up study. BMC Endocr. Disord. 23 (1), 125. https:\/\/doi.org\/10.1186\/s12902-023-01375-6 (2023).","journal-title":"BMC Endocr. Disord"},{"issue":"3","key":"28483_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.14639\/0392-100X-N1412","volume":"41","author":"A Ywata de Carvalho","year":"2021","unstructured":"Ywata de Carvalho, A., Kohler, H. F., Gomes, C. C., Vartanian, J. G. & Kowalski, L. P. Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients. Acta Otorhinolaryngol. Ital. 41 (3), 236\u2013242. https:\/\/doi.org\/10.14639\/0392-100X-N1412 (2021).","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"28483_CR39","doi-asserted-by":"publisher","unstructured":"Yang, Z., Heng, Y., Qiu, W., Tao, L. & Cai, W. Cervical Lymph Node Metastasis Differences in Patients with Unilateral or Bilateral Papillary Thyroid Microcarcinoma: A Multi-Center Analysis. J. Clin. Med. 11(16), https:\/\/doi.org\/10.3390\/jcm11164929 (2022).","DOI":"10.3390\/jcm11164929"},{"issue":"1","key":"28483_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12885-025-14112-0","volume":"25","author":"J Wang","year":"2025","unstructured":"Wang, J., Fu, W., Luo, J., Wei, M. & Dai, Y. Development of a clinical-molecular prediction model for central lymph node metastasis in cN0 stage papillary thyroid microcarcinoma: a retrospective study. BMC Cancer. 25 (1), 693. https:\/\/doi.org\/10.1186\/s12885-025-14112-0 (2025).","journal-title":"BMC Cancer"},{"key":"28483_CR41","doi-asserted-by":"publisher","unstructured":"Ren, Y. et al. Initial ablation ratio predicts the recurrence of low-risk papillary thyroid microcarcinomas treated with microwave ablation: a 5-year, single-institution cohort study. Endocr. Connect. 12(9), https:\/\/doi.org\/10.1530\/EC-23-0128 (2023).","DOI":"10.1530\/EC-23-0128"},{"issue":"12","key":"28483_CR42","doi-asserted-by":"publisher","first-page":"12403","DOI":"10.21037\/apm-21-3379","volume":"10","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Xing, P., Hao, X. & Li, J. Clinical value of serum albumin level in patients with non-small cell lung cancer and anaplastic lymphoma kinase (ALK) rearrangement. Ann. Palliat. Med. 10 (12), 12403\u201312411. https:\/\/doi.org\/10.21037\/apm-21-3379 (2021).","journal-title":"Ann. Palliat. Med."},{"issue":"8","key":"28483_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2217\/fon-2019-0732","volume":"16","author":"J Lei","year":"2020","unstructured":"Lei, J. et al. Low preoperative serum ALB level is independently associated with poor overall survival in endometrial cancer patients. Future Oncol. 16 (8), 307\u2013316. https:\/\/doi.org\/10.2217\/fon-2019-0732 (2020).","journal-title":"Future Oncol."},{"issue":"6","key":"28483_CR44","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4149\/neo_2021_210331N435","volume":"68","author":"R Z\u00e1horec","year":"2021","unstructured":"Z\u00e1horec, R. et al. Predictive model using hemoglobin, albumin, fibrinogen, and neutrophil-to-lymphocyte ratio to distinguish patients with colorectal cancer from those with benign adenoma. Neoplasma 68 (6), 1292\u20131300. https:\/\/doi.org\/10.4149\/neo_2021_210331N435 (2021).","journal-title":"Neoplasma"},{"issue":"1","key":"28483_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.amjsurg.2020.08.002","volume":"221","author":"H Ata\u015f","year":"2021","unstructured":"Ata\u015f, H. et al. Diagnostic value of modified systemic inflammation score for prediction of malignancy in patients with indeterminate thyroid nodules. Am. J. Surg. 221 (1), 117\u2013121. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.08.002 (2021).","journal-title":"Am. J. Surg."},{"issue":"6","key":"28483_CR46","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.7150\/jca.69321","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. A new prediction model integrated serum lipid profile for patients with multiple myeloma. J. Cancer. 13 (6), 1796\u20131807. https:\/\/doi.org\/10.7150\/jca.69321 (2022).","journal-title":"J. Cancer"},{"issue":"1","key":"28483_CR47","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3892\/ol.2020.11617","volume":"20","author":"XQ Chen","year":"2020","unstructured":"Chen, X. Q. et al. Prognostic significance of high triglyceride and Apolipoprotein B levels in patients with stage III and high-risk stage II colorectal cancer undergoing curative surgery. Oncol. Lett. 20 (1), 705\u2013714. https:\/\/doi.org\/10.3892\/ol.2020.11617 (2020).","journal-title":"Oncol. Lett."},{"issue":"1","key":"28483_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/thy.2018.0190","volume":"29","author":"GA Sigal","year":"2019","unstructured":"Sigal, G. A. et al. Effects of Short-Term hypothyroidism on the lipid transfer to High-Density lipoprotein and other parameters related to lipoprotein metabolism in patients submitted to thyroidectomy for thyroid cancer. Thyroid 29 (1), 53\u201358. https:\/\/doi.org\/10.1089\/thy.2018.0190 (2019).","journal-title":"Thyroid"},{"key":"28483_CR49","doi-asserted-by":"publisher","unstructured":"Bobin-Dubigeon, C., Nazih, H., Croyal, M. & Bard, J. M. Link between Omega 3 Fatty Acids Carried by Lipoproteins and Breast Cancer Severity. Nutrients 14(12), https:\/\/doi.org\/10.3390\/nu14122461 (2022).","DOI":"10.3390\/nu14122461"},{"key":"28483_CR50","doi-asserted-by":"publisher","first-page":"937049","DOI":"10.3389\/fendo.2022.937049","volume":"13","author":"Q Chang","year":"2022","unstructured":"Chang, Q. et al. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis. Front. Endocrinol. (Lausanne). 13, 937049. https:\/\/doi.org\/10.3389\/fendo.2022.937049 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"28483_CR51","doi-asserted-by":"publisher","first-page":"103023","DOI":"10.1016\/j.amjoto.2021.103023","volume":"42","author":"A Dirikoc","year":"2021","unstructured":"Dirikoc, A. et al. Papillary thyroid microcarcinomas that metastasize to lymph nodes. Am. J. Otolaryngol. 42 (5), 103023. https:\/\/doi.org\/10.1016\/j.amjoto.2021.103023 (2021).","journal-title":"Am. J. Otolaryngol."},{"issue":"1","key":"28483_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12902-019-0450-8","volume":"19","author":"JH Gu","year":"2019","unstructured":"Gu, J. H. et al. Analysis of risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma: a study of 268 patients. BMC Endocr. Disord. 19 (1), 124. https:\/\/doi.org\/10.1186\/s12902-019-0450-8 (2019).","journal-title":"BMC Endocr. Disord"},{"issue":"2","key":"28483_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40618-018-0908-y","volume":"42","author":"Y Luo","year":"2019","unstructured":"Luo, Y. et al. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma. J. Endocrinol. Invest. 42 (2), 227\u2013236. https:\/\/doi.org\/10.1007\/s40618-018-0908-y (2019).","journal-title":"J. Endocrinol. Invest."},{"key":"28483_CR54","doi-asserted-by":"publisher","first-page":"742328","DOI":"10.3389\/fsurg.2021.742328","volume":"8","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. A nomogram based on clinicopathological and ultrasound imaging characteristics for predicting cervical lymph node metastasis in cN0 unilateral papillary thyroid microcarcinoma. Front. Surg. 8, 742328. https:\/\/doi.org\/10.3389\/fsurg.2021.742328 (2021).","journal-title":"Front. Surg."},{"key":"28483_CR55","doi-asserted-by":"publisher","first-page":"644645","DOI":"10.3389\/fonc.2021.644645","volume":"11","author":"Y Yin","year":"2021","unstructured":"Yin, Y. et al. Influencing factors and cumulative risk analysis of cervical lymph node metastasis of papillary thyroid microcarcinoma. Front. Oncol. 11, 644645. https:\/\/doi.org\/10.3389\/fonc.2021.644645 (2021).","journal-title":"Front. Oncol."},{"issue":"5","key":"28483_CR56","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/sdi.12731","volume":"31","author":"H Mukai","year":"2018","unstructured":"Mukai, H., Villafuerte, H., Qureshi, A. R., Lindholm, B. & Stenvinkel, P. Serum albumin, inflammation, and nutrition in end-stage renal disease: C-reactive protein is needed for optimal assessment. Semin Dial. 31 (5), 435\u2013439. https:\/\/doi.org\/10.1111\/sdi.12731 (2018).","journal-title":"Semin Dial"},{"issue":"2","key":"28483_CR57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10047-011-0561-0","volume":"14","author":"N Zhu","year":"2011","unstructured":"Zhu, N. et al. High mobility group box protein-1 correlates with microinflammatory state and nutritional status in continuous ambulatory peritoneal Dialysis patients. J. Artif. Organs. 14 (2), 125\u2013132. https:\/\/doi.org\/10.1007\/s10047-011-0561-0 (2011).","journal-title":"J. Artif. Organs"},{"issue":"1","key":"28483_CR58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s40001-025-02925-5","volume":"30","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Dynamic association of serum albumin changes with inflammation, nutritional status and clinical outcomes: a secondary analysis of a large prospective observational cohort study. Eur. J. Med. Res. 30 (1), 679. https:\/\/doi.org\/10.1186\/s40001-025-02925-5 (2025).","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"28483_CR59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12672-024-00877-6","volume":"15","author":"Z Lin","year":"2024","unstructured":"Lin, Z., Ji, X., Tian, N., Gan, Y. & Ke, L. APOB is a potential prognostic biomarker in hepatocellular carcinoma. Discov Oncol. 15 (1), 28. https:\/\/doi.org\/10.1007\/s12672-024-00877-6 (2024).","journal-title":"Discov Oncol."},{"key":"28483_CR60","doi-asserted-by":"publisher","first-page":"654689","DOI":"10.3389\/fonc.2021.654689","volume":"11","author":"X Xu","year":"2021","unstructured":"Xu, X. et al. Apolipoprotein B is associated with the microenvironment of cholangiocarcinoma. Front. Oncol. 11, 654689. https:\/\/doi.org\/10.3389\/fonc.2021.654689 (2021).","journal-title":"Front. Oncol."},{"issue":"6","key":"28483_CR61","doi-asserted-by":"publisher","first-page":"389","DOI":"10.21037\/atm.2019.10.92","volume":"8","author":"Z Huang","year":"2020","unstructured":"Huang, Z. et al. Preoperative serum thyroglobulin is a risk factor of skip metastasis in papillary thyroid carcinoma. Ann. Transl Med. 8 (6), 389. https:\/\/doi.org\/10.21037\/atm.2019.10.92 (2020).","journal-title":"Ann. Transl Med."},{"issue":"5","key":"28483_CR62","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3892\/ol.2025.15266","volume":"30","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Thyroid cancer: from molecular insights to therapy (Review). Oncol. Lett. 30 (5), 520. https:\/\/doi.org\/10.3892\/ol.2025.15266 (2025).","journal-title":"Oncol. Lett."},{"issue":"6","key":"28483_CR63","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.ajhg.2016.04.014","volume":"98","author":"AK Siraj","year":"2016","unstructured":"Siraj, A. K. et al. Genomic profiling of thyroid cancer reveals a role for thyroglobulin in metastasis. Am. J. Hum. Genet. 98 (6), 1170\u20131180. https:\/\/doi.org\/10.1016\/j.ajhg.2016.04.014 (2016).","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"28483_CR64","doi-asserted-by":"publisher","first-page":"e1211","DOI":"10.1002\/ctm2.1211","volume":"13","author":"DH Seo","year":"2023","unstructured":"Seo, D. H. et al. Lymph node metastasis-dependent molecular classification in papillary thyroid carcinoma defines aggressive metastatic outgrowth. Clin. Transl Med. 13 (3), e1211. https:\/\/doi.org\/10.1002\/ctm2.1211 (2023).","journal-title":"Clin. Transl Med."},{"issue":"2","key":"28483_CR65","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10238-020-00675-8","volume":"21","author":"ZY Rui","year":"2021","unstructured":"Rui, Z. Y. et al. A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis. Clin. Exp. Med. 21 (2), 277\u2013286. https:\/\/doi.org\/10.1007\/s10238-020-00675-8 (2021).","journal-title":"Clin. Exp. Med."},{"issue":"11","key":"28483_CR66","doi-asserted-by":"publisher","first-page":"730","DOI":"10.34172\/aim.2022.115","volume":"25","author":"S Altiner","year":"2022","unstructured":"Altiner, S., Kozan, R., Emral, A. C., Taneri, F. & Karamercan, A. Effects of patient and tumor characteristics on central lymph node metastasis in papillary thyroid cancer: A guide for selective node dissection. Arch. Iran. Med. 25 (11), 730\u2013736. https:\/\/doi.org\/10.34172\/aim.2022.115 (2022).","journal-title":"Arch. Iran. Med."},{"issue":"3","key":"28483_CR67","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12020-016-0955-0","volume":"53","author":"AA Tam","year":"2016","unstructured":"Tam, A. A. et al. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer. Endocrine 53 (3), 774\u2013783. https:\/\/doi.org\/10.1007\/s12020-016-0955-0 (2016).","journal-title":"Endocrine"},{"key":"28483_CR68","doi-asserted-by":"crossref","unstructured":"Jara, S. M. et al. The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma. Surgery 154(6), 1272-1280-discussion 1280-1282. https:\/\/doi.org\/10.1016\/j.surg.2013.07.021 (2013).","DOI":"10.1016\/j.surg.2013.07.021"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28483-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:37:45Z","timestamp":1777127865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28483-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28483-8","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.jacr.2017.01.046","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approved by the Medical Ethics Committee of Huzhou Central Hospital (202207002-01), the written informed consent of the subjects was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\u00a0<!--Emphasis Type='Bold' removed-->and informed consent"}},{"value":"All authors gave consent for the publication of the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"45288"}}